Target intelligence / Profile preview

Secretoglobin family 2B member 2 (SCGB2B2)

Target
SCGB2B2
Molecular classification
Secretoglobin family, small secreted protein
01

Overview

Secretoglobin family 2B member 2 is a small, secreted protein comprising 96 amino acids, encoded by the SCGB2B2 gene (HGNC:27616, NCBI Gene:284402, UniProt:Q4G0G5)[1][4][6]. It belongs to the **secretoglobin** superfamily, which is expressed mainly in mammalian tissues and is known for involvement in immune modulation, tissue repair, and possibly tumorigenesis[2]. However, the specific roles, tissue localization, and interacting partners of SCGB2B2 remain largely uncharacterized in the scientific literature[1][2]. It is phylogenetically related to other secretoglobins and may share general features such as roles in secretion and dimer formation but has not been directly implicated as a receptor, enzyme, or transporter nor as a drug target. No clinical biomarkers or safety concerns have been reported for SCGB2B2[1][2][6].

Other names
SCGB2B2SCGB4A2SCGBLsecretoglobin-like protein
02

Mechanism of action

None (not recognized as a therapeutic drug target)

03

Biological functions

Putative roles in immune modulationpossible involvement in tissue repair and inflammation (inferred from secretoglobin family features)not specifically established for SCGB2B2 itself
04

Disease associations

No confirmed disease associationother secretoglobins have roles in cancer and inflammationdatabase links to prolidase deficiencydatabase links to congenital muscular dystrophy (these associations may represent data overlaps or indirect links rather than causative relationships)
05

Safety considerations

None known or reported
06

Interacting drugs

None (no known drugs interact with SCGB2B2)
07

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Secretoglobin family 2B member 2 (SCGB2B2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Secretoglobin family 2B member 2 (SCGB2B2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call